ArticleFrontiers in oncology2025

Real-world cardiovascular risks of ibrutinib in chronic lymphocytic leukemia: a retrospective study.

Jelena Ivanovic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.